文献速递免疫规划

基于mRNA的SARS-CoV-2候选疫苗单剂接种可诱导稳定免疫应答

An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose.
PubMed 文献 · Vaccine · 2021-05-18

该研究开发了针对SARS-CoV-2 D614G变异株的mRNA-LNP疫苗,并在动物模型中评估其免疫原性。表面等离子共振显示免疫后产生针对刺突蛋白胞外域(RBD和S2)的特异性抗体;免疫小鼠的抗血清和纯化IgG在表达ACE2的HEK293细胞中以剂量依赖方式中和SARS-CoV-2假病毒。单剂免疫保护小鼠肺免受同型假病毒入侵和细胞病变,CD4+细胞反应平衡稳定且偏向Th1。

要点

  • D614G变异株mRNA-LNP疫苗在动物模型中诱导针对刺突蛋白RBD和S2的特异性抗体。
  • 免疫小鼠抗血清和纯化IgG剂量依赖性中和SARS-CoV-2假病毒。
  • 单剂免疫保护小鼠肺免受同型假病毒入侵和细胞病变。

核心结论

  • 针对D614G变异株的mRNA-LNP疫苗在动物模型中单剂接种可诱导稳定免疫应答并保护肺部。

研究设计与样本

  • 研究在动物模型中开发并评估了针对SARS-CoV-2 D614G变异株的mRNA-LNP疫苗。

主要发现

  • 表面等离子共振数据表明免疫后产生针对刺突蛋白胞外域(RBD和S2)的特异性抗体池。
  • 免疫小鼠的抗血清和纯化IgG在表达ACE2的HEK293细胞中以剂量依赖方式中和SARS-CoV-2假病毒。
  • 单剂免疫保护小鼠肺免受同型假病毒入侵和细胞病变。
  • 免疫应答涉及平衡稳定的CD4+细胞群且偏向Th1。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

D614G genotype of SARS-CoV-2 virus is highly infectious and responsible for almost all infection for 2nd wave. However, there are currently no reports with D614G as vaccine candidate. Here we report the development of an mRNA-LNP vaccine with D614G variant and characterization in animal model. We have used special mRNA-architecture and formulation that provides suitable response of the product. The surface plasmon resonance (SPR) data with spike protein (S) revealed that immunization generated specific antibody pools against the whole extracellular domain (RBD and S2) of the spike protein. The anti-sera and purified IgGs from immunized mice neutralized SARS-CoV-2-pseudoviruses in ACE2-expressing HEK293 cells in a dose dependent manner. Importantly, single-dose immunization protected mice-lungs from homotypic-pseudovirus entry and cytopathy. The immunologic responses have been implicated by a balanced and stable population of CD4+ cells with a Th1 bias. The data suggested great promise for immediate translation of the technology to the clinic.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Nag K, Chandra Baray J, Rahman Khan M, et al. An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose. Vaccine. 2021. PMID: 34039497. doi:10.1016/j.vaccine.2021.05.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。